SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-024481
Filing Date
2022-04-14
Accepted
2022-04-14 19:49:22
Documents
2
Period of Report
2022-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1527
2 EX-24 DOCUMENT attachment1.htm EX-24 2171
  Complete submission text file 0001209191-22-024481.txt   5077
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALX ONCOLOGY HOLDINGS INC 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Canamasas Itziar (Reporting) CIK: 0001921346 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39386 | Film No.: 22828710